Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
114.61
-1.45 (-1.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Dexcom Inc
< Previous
1
2
3
4
Next >
Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
September 29, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program
September 19, 2023
From
Dexcom, Inc.
Via
Business Wire
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
September 05, 2023
General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to.
Via
MarketBeat
Dexcom Announces Upcoming Conference Presentations
August 30, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Appoints Rimma Driscoll to Board of Directors
August 28, 2023
From
DexCom, Inc.
Via
Business Wire
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher
July 31, 2023
Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans.
Via
MarketBeat
Dexcom Reports Second Quarter 2023 Financial Results
July 27, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
July 06, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
July 04, 2023
From
Dexcom, Inc.
Via
Business Wire
Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More
June 23, 2023
From
Dexcom, Inc.
Via
Business Wire
Dexcom Updates Long-Range Financial Targets
June 23, 2023
From
DexCom, Inc.
Via
Business Wire
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
June 21, 2023
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next.
Via
MarketBeat
DarioHealth is an AI-Powered Digital Therapeutics Play
June 13, 2023
DarioHealth Co. (NASDAQ: DRIO) is an AI-powered digital therapeutics platform and provider that adaptively personalizes monitoring and treatments for chronic
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Dexcom to Host Investor Day on June 23, 2023
June 08, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentation
June 01, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
May 03, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
May 02, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Reports First Quarter 2023 Financial Results
April 27, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB
April 27, 2023
From
Dexcom, Inc.
Via
Business Wire
3 Medtech Companies with Higher Future Share Prices
April 24, 2023
The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond.
Via
MarketBeat
Diversified Abbott Laboratories Could Reverse And Move Higher
April 19, 2023
Abbott Laboratories reported a solid quarter driven by gains in the core business that are accelerating as COVID sales decline.
Via
MarketBeat
Exposures
COVID-19
Healthcare Innovation Drives Medical Device Makers To New Highs
April 17, 2023
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base.
Via
MarketBeat
Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin
April 17, 2023
From
Dexcom, Inc.
Via
Business Wire
Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time
April 06, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Publishes Annual Sustainability Report
April 05, 2023
From
DexCom, Inc.
Via
Business Wire
DexCom Comments on SVB Relationship
March 13, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom Announces Upcoming Conference Presentations
February 23, 2023
From
DexCom, Inc.
Via
Business Wire
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
February 13, 2023
From
Dexcom, Inc.
Via
Business Wire
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 09, 2023
From
DexCom, Inc.
Via
Business Wire
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
February 08, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.